Clinical Trials Logo

Total Hip Replacement clinical trials

View clinical trials related to Total Hip Replacement.

Filter by:
  • Not yet recruiting  
  • Page 1

NCT ID: NCT04219098 Not yet recruiting - Arthroplasty Clinical Trials

Pain After Preoperative UltraSound Guided Hip Injections for Total Hip Arthroplasty (PUSH)

PUSH
Start date: February 1, 2020
Phase: N/A
Study type: Interventional

The purpose of the study is to assess the accuracy of Butterfly IQ ultrasound for intra-articular hip injections, and to see if an injection given intra-articular before incision provides any benefit in preemptive pain relief or blood loss reduction.

NCT ID: NCT03741296 Not yet recruiting - Clinical trials for Arthroplasty Complications

REVISITS: Revision Single or Two Stage Surgery

REVISITS
Start date: April 2019
Phase: N/A
Study type: Interventional

Hip replacement surgery is common, with over 60,000 cases in Canada annually. After hip replacement, about 1-2% patients develop a deep infection in their artificial hip implant, called a periprosthetic joint infection (PJI). It can results in severe pain, disability and death. There are two types of surgical treatment: a single-stage revision that involves removing the joint, thoroughly cleaning the infected area and implanting a new joint, all in the same surgical procedure; a two-stage revision involves removing the joint, waiting at least 8 weeks while treating the patients with antibiotics and then doing re-implantation of the joint.

NCT ID: NCT02272205 Not yet recruiting - Clinical trials for Total Hip Replacement

Evaluation of Conventional Antibiotic Prophylaxis During a Change of Hip or Knee Infected at a Time

Start date: November 2014
Phase: N/A
Study type: Observational

Infection is a serious complications after undergoing total hip replacement. It occurs in about 1% of cases. The optimal treatment of these infections is discussed. The team validated by international publications change strategy of the infected prosthesis at a time. Antibiotic prophylaxis has significantly reduced the infection intraoperative contamination in orthopedic surgery rates. It must be conventionally administered before the surgical incision. In response to infection, it is typically recommended to start this antibiotic after the completion of the deep bacteriological samples, so as not to negate the risk of these samples by the prior administration of antibiotics. This attitude, however, is not formally validated by the scientific literature. In contrast, two recent publications challenge this practice, and suggest the use of a conventional antibiotic prophylaxis even in septic interventions. Our multidisciplinary team opted for a few months for this new strategy. We wish to evaluate the influence of this new approach results in the treatment of infection in total hip or knee.